Market News
Monday, June 20, 2016
BRIEF-Caladrius unit to manufacture Phase 3 cell therapy product for Kiadis Pharma
* Kiadis Pharma appoints PCT as its contract manufacturing
organization in the United States
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment